Materials and methods
finger contracture
RHEUMATOID ARTHRITIS, NEUROLOGICAL DISEASE, TRIGGER FINGER, DISEASES, COMPLICATIONS
The present study was designed as a prospective controlled study and initiated upon the approval of the local ethics committee. The present study included successive patients with Quinnel stage 2,3 or 4 trigger fingers who did not respond to the conservative treatment (splint, non-steroidal anti-inflammatory, drugs and exercise) and gave their consent on the patient consent form. The two groups of patients treated with blinded injection (BG) or USG-guided injection (UG) were compared in terms of demographic data, trigger recovery time, QDASH (Quick Disability of Arm, Shoulder and Hand) scores, VAS (Visual Analogue Scale) scores, time until return to work, complications, and other diseases. QDASH scores of the patients were recorded before the injection and at 1–4 to 12–24 weeks after the injection. Their VAS scores were recorded before and after injection.Patients over the age of 18 who had no history of treatment or surgery for trigger fingers were included in the study. The exclusion criteria herein were having congenital trigger fingers, having multiple trigger fingers, having a neurological disease, having finger contracture, and having rheumatoid arthritis.In the blinded injection, patients were positioned in a sitting position with the elbow in 90The Samsung trademark ultrasound device and the LA2-14A linear probe with a frequency of 2.0–14.0 MHz were used for ultrasound-guided injections. In the USG-guided injection, patients were positioned in a sitting position with their elbow in 90Ultrasound guided trigger finger injection. Arrow: 27 G needle, + : inside of the swollen flexor tendon sheath after injection, In both groups of the two techniques, the patients were examined for their VAS and QDASH scores at the time of their first-week follow-up, and in those who demonstrated no improvement, the injection was repeated.